GGrantIndex
Sort

39,280 grants matching leukemia

Cytotoxic-T-Lymphocyte (CTL) Therapy of AML

$298,185
Bruce R. Blazar · University Of Minnesota · R01 · FY2007 · CA

Cytotoxic-T-Lymphocyte (CTL) Therapy of AML

$298,185
Bruce R. Blazar · University Of Minnesota · R01 · FY2010 · CA

Cytotoxic-T-Lymphocyte (CTL) Therapy of AML

$298,185
Bruce R. Blazar · University Of Minnesota · R01 · FY2009 · CA

Cytotoxic-T-Lymphocyte (CTL) Therapy of AML

$298,185
Bruce R. Blazar · University Of Minnesota · R01 · FY2008 · CA

ALL Fusion Proteins: Associated with Multi-protein Complexes and Role in Transcri

$298,169
Carlo M Croce · Ohio State University · R01 · FY2007 · CA

MECHANISMS OF RETROVIRUS INDUCED T AND NEURAL CELL DEATH

$298,168
University Of Texas Md Anderson Can Ctr · R01 · FY2001 · AI

REGULATION OF FELV REPLICATION AND PATHOGENESIS

$298,163
Fred Hutchinson Cancer Research Center · R01 · FY2001 · CA

In Search of Stem Leydig Cells: Identification, Isolation & Development

$298,144
Ren-Shan Ge · Population Council · R01 · FY2007 · HD

Genetic and Molecular Studies of Drosophila Chromatin Remodeling Factors

$298,121
John Walter Tamkun · University Of California Santa Cruz · R01 · FY2008 · GM

NPM/MLF1 IN LEUKEMIA AND NORMAL DEVELOPMENT

$298,120
St. Jude Children'S Research Hospital · R01 · FY2000 · CA

FANCONI ANEMIA GENE FUNCTION IN GENOME STABILITY AND TUMOR SUPPRESSION

$298,118
Oregon Health And Science University · P01 · FY2004 · HL

Acetylation-Dependent IFN Signal Transduction

$298,100
Y. Eugene Chin · Rhode Island Hospital · R01 · FY2010 · GM

CYTOKINES CONVERT EPITHELIAL PRECURSORS TO NEPHRONS

$298,096
Columbia University Health Sciences · R01 · FY2001 · DK

Translating CD33 genetic mechanism into a novel Alzheimers therapeutic

$298,018
Steven Estus · University Of Kentucky · R01 · FY2015 · AG

Aptamer-Modified POSH Inhibitor Micelles as a Novel Leukemia Treatment Modality

$298,013
Bret Daniel Ulery · University Of Missouri-Columbia · R21 · FY2019 · EB

MAPPING AND CLONING TRANSLOCATION BREAKPOINTS

$298,009
University Of Chicago · R01 · FY2001 · CA

TRANSCRIPTION FACTOR MUTATIONS AND HUMAN AML

$298,008
Beth Israel Deaconess Medical Center · R01 · FY2003 · CA

SAG E3 ubiquitin ligase in angiogenesis & carcinogenesis

$298,007
Yi Sun · University Of Michigan At Ann Arbor · R01 · FY2010 · CA

Drug-Free Macromolecular Therapeutics

$298,000
Jindrich N. Kopecek · University Of Utah · R01 · FY2018 · GM

Drug-Free Macromolecular Therapeutics

$298,000
Jindrich N. Kopecek · University Of Utah · R01 · FY2017 · GM

Drug-Free Macromolecular Therapeutics

$298,000
Jindrich N. Kopecek · University Of Utah · R01 · FY2016 · GM

Drug-Free Macromolecular Therapeutics

$298,000
Jindrich N. Kopecek · University Of Utah · R01 · FY2015 · GM

The deubiquitinating inhibitor EerI induces tumor cell apoptosis

$297,997
Yihong Ye · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK

MOLECULAR ANALYSIS OF B-LYMPHOCYTE RESTRICTED PROTEINS

$297,996
Duke University · R01 · FY2001 · CA

APOPTOSIS OF CARDIAC MUSCLE AS A TARGET FOR GENE THERAPY

$297,982
Baylor College Of Medicine · R01 · FY2002 · HL